Your body on GLP-1 drugs.
Medical

Your body on GLP-1 drugs.

Staff Reporter 869 Views 0 Comments

Listen & Subscribe

Choose your preferred player:

For questions about subscriptions or your Slate Plus feed, check our FAQ.

Get Your Slate Plus Podcast

Listen on your phone:RECOMMENDED

Enter your phone number and we’ll text you a link to set up the
podcast in your app:

Text me the link!

We’ll only text you about setting up this podcast, no spam.

Listen on your computer:

Apple Podcasts will only work on MacOS operating systems since Catalina. We do not support Android apps on desktop at this time.

Listen on your device:RECOMMENDED

These links will only work if you’re on the device you listen to podcasts on.

question mark

We are showing you options for a computer but if you’re on a phone or tablet
We are showing you options for a phone or a tablet but if you’re on a computer,
click here. If you still have questions about subscriptions or your Slate Plus Feed, check our FAQ.

Episode Notes

GLP-1 drugs like Ozempic, WeGovy, Mounjaro and others revolutionized weight loss and chronic weight management. But what does it feel like for the patients who take them?

On this week’s episode of Well, Now Kavita and Maya talk with journalist and author Johann Hari. Over the course of a year, Johann dived into the research and history behind GLP-1 drugs and how they became the latest and most effective way to lose weight. All the while, he was also taking Ozempic himself.

His latest book Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs takes a personal and research-based look at the revolutionary, controversial rise of GLP-1 drugs for weight management.

If you liked this episode, check out: The Full Truth About Ozempic and Doctors Agree: Obesity is a Disease. The Public Needs to Catch Up.

Well, Now is hosted by registered dietitian nutritionist Maya Feller and Dr. Kavita Patel.

Podcast production by Vic Whitley-Berry with editorial oversight by Alicia Montgomery.

Send your comments and recommendations on what to cover to wellnow@slate.com

Want to listen to Well, Now uninterrupted? Subscribe to Slate Plus to immediately unlock ad-free listening to Well, Now and all your other favorite Slate podcasts.

Subscribe now on Apple Podcasts by clicking “Try Free” at the top of our show page. Or, visit slate.com/wellplus to get access wherever you listen.

This Content is Available for Slate Plus members only

Bonus Episode

Bonus | Why Johann Hari Decided to Take Ozempic

It’s been more than a year, and he still has mixed feelings about it.

No Byline Policy

Editorial Guidelines

Corrections Policy

Source

Leave a Reply